Publications du Docteur Monsonego

Infection à papillomavirus humains (HPV) et pathologies associées, dépistage, prévention, diagnostic et traitement.

1. Epidémiologie HPV

VIN-VAIN-HPV-PREVALENCE.jpg

VIN VAIN HPV PREVALENCE
Human Papillomavirus Genotypes From Vaginal and Vulvar Intraepithelial Neoplasia in Young Women

(Obstet Gynecol Jan 18,2018)

attribution-of-high-risk-human-papilloma

Attribution of 12 High-Risk Human Papillomavirus Genotypes to Infection and Cervical Disease.

(Cancer Epidemiol Biomarkers Prev October 2014 23:10 1997-2008)

JVAC13270-2.jpg

Prevalence of type-specific human papillomavirus infection among women in France: Implications for screening, vaccination, and a future generation of multivalent HPV vaccines.

(Vaccine 30, 2012, 5215–5221)

prevalence-of-high-risk-human-papilloma-

Prevalence of high-risk human papilloma virus genotypes and associated risk of cervical precancerous lesions in a large U.S. screening population: Data from the ATHENA trial.

(Gynecol Oncol, January 2015)

Prevalence-des-genotypes.jpg

Prévalence des génotypes d’HPV chez les femmes en France:implications pour le dépistage et la vaccination.

(Gynécol. Obstét. Fertil, 2013;41:305–313)

prevalence-de-l-infection-a-hpv-en-franc

Prévalence de l’infection à HPV en France, impact attendu de la vaccination et du dépistage pour la prévention du cancer du col utérin.

(Vaccine, 30, 2012, 5215‐522)

2. Dépistage du cancer du col

depistage-cancer-uterin-un-tournant.jpg

Dépistage du cancer du col utérin : un tournant ?

Gynécologie Obstétrique Pratique 28/11/2017

Cytologie-en-phase-liquide-dans-le-cadre

Cytologie en phase liquide dans le cadre d’un dépistage primaire du cancer du col utérin : une étude multicentrique.

(Gynécol Obstét Fertil 2001 ; 29 : 1-9) 

Evaluation-of-oncogenic-human-papillomav

Evaluation of oncogenic human papillomavirus RNA and DNA tests with liquid-based cytology in primary cervical cancer screening: the FASE study.

Int. J. Cancer: 129, 691–701 (2011)

liquid-based-cytology-for-primary-cervic

Liquid-based cytology for primary cervical cancer screening: a multi-centre study.

Br J Cancer. 2001 Feb 2;84(3):360-6.

3. Vaccination HPV

jlemte00590.jpg

Vaccination HPV dans la vraie vie : dix années d’expérience
mt Médecine de la Reproduction, Gynécologie

Endocrinologie, vol. 18, n◦ 1, janvier-février-mars 2016

end-of-study-safety-immunogenicity-and-e

End of study safety, immunogenicity, and efficacy of quadrivalent (types 6, 11, 16, 18) recombinant vaccine in adult women 24 to 45 years of age.

Br J Cancer. 2011 Jun 28;105(1):28-37

Prevention-du-cancer-du-col-uterin.jpg

Prévention du cancer du col utérin : enjeux et perspectives de la vaccination antipapillomavirus

(Gynecol Obstet Fertil, 2006 Mar ; 34 (3):189-201)

col_2_Monsonego_bat1_zb.jpg

Profil de sécurité des vaccins papillomavirus : mise au point
(2015)

CNGOF 2015

Benefits-of-vaccinating-young-adult-wome

Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine. 

Vaccine 28 (2010) 8065–8072

4. Optimisation de la colposcopie

risk-assessment-and-clinical-impact-of-l

Risk assessment and clinical impact of liquid-based cytology, oncogenic human papillomavirus (HPV) DNA and mRNA testing in primary cervical cancer screening

(The FASE Study). (Gynecologic Oncology 125, 2012, 175–180)

performance-of-the-roche-amplicor.jpg

Performance of the Roche AMPLICOR Human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear.

(Gynecologic Oncology 99, 2005, 160 – 168)

human-papillomavirus-testing-improves-th

Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.

(Int J Gynecol Cancer. 2006 Mar-Apr;16(2):591-8 )

colposcopie-apport-du-test-hpv-en-pratiq

Colposcopie : apport du test HPV en pratique clinique.

(Gynecol Obstet Fertil. 2004 Jan;32(1):62-74)

5. Transmission / Rôle de l'homme

Male-circumcision-for-prevention.jpg

Male circumcision for prevention of oncogenic HPV infection — Author's reply.

genital-human-papillomavirus-infections-

Genital human papillomavirus infections: correlation of cytological, colposcopic and histological features with viral types in women and their male partners.

genital-infection-with-hpv-in-men-transl

Genital infection with HPV in men: translating research into practice.

(Vaccine. 2011 Jan 17;29(4):624-8)

6. Perception des femmes

psychological-impact-support-and-informa

Psychological impact, support and information needs for women with an abnormal Pap smear: comparative results of a questionnaire in three European countries. 

civil-society-a-critical-new-advocate-fo

Civil society: A critical new advocate for vaccination in Europe.

(Vaccine. 2011 Jan 17;29(4):624-8)

perception-et-impact-psychologique-du-fr

Perception et impact psychologique du frottis anormal en France. Résultats comparatifs d’une enquête européenne. 

7. HPV / EUROGIN Roadmap - Consensus d'experts internationaux

EUROGIN 2017 Roadmap.jpg

Eurogin 2017 Roadmap: Triage strategies for the managment of HPV-positive women in cervical screening programs

Kate Cuschieri 1 , Guglielmo Ronco 2 , Attila Lorincz 3 , Laurie Smith4 , Gina Ogilvie5 , Lisa Mirabello6 , Francesca Carozzi7 , Heather Cubie8 , Nicolas Wentzensen6 , Peter Snijders9 , Marc Arbyn10, Joe Monsonego11 and Silvia Franceschi12

Int J Cancer. 2018 Aug 15;143(4):735-745

Brotherton_Roadmap_IJC_2016.jpg

Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines

Julia M.L. Brotherton1,2, Mark Jit3,4, Patti E. Gravitt5 , Marc Brisson6 , Aimee R. Kreimer 7 , Sara I. Pai8 , Carole Fakhry9 , Joseph Monsonego10 and Silvia Franceschi11

Int J Cancer. 2016 Aug 1;139(3):510-7

eurogin-2012-roadmap.jpg

EUROGIN 2012 roadmap on Comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix

Maura L. Gillison1 , Xavier Castellsague2 , Anil Chaturvedi3 , Marc T. Goodman4 , Peter Snijders5 , Massimo Tommasino6 , Marc Arbyn7,8 and Silvia Franceschi6

Int J Cancer. 2014 Feb 1;134(3):497-507

eurogin-2011-roadmap.jpg

EUROGIN 2010 roadmap on cervical cancer prevention

Silvia Franceschi1 , Lynette Denny2 , Kathleen L. Irwin1*, Jose´ Jeronimo3 , Pier Luigi Lopalco4 , Joseph Monsonego5 , Julian Peto6 , Guglielmo Ronco7 , Peter Sasieni8 and Cosette M. Wheeler9

Int J Cancer. 2011 Jun 15;128(12):2765-74

eurogin-2007-roadmap-on-cervical-cancer.

EUROGIN 2007 roadmap on cervical cancer prevention

eurogin-2007-roadmap-on-cervical-cancer.

EUROGIN 2007
Patient Education Conference Report
Part 2

eurogin-2007-roadmap-on-cervical-cancer.

EUROGIN 2004
Recommendations guidelines

(Gynecol Oncol. 2005 Mar;96(3):830-9.)

eurogin-roadmap2016-1.jpg

Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice

Nicolas Wentzensen1 , Marc Arbyn2 , Johannes Berkhof3 , Mark Bower4 , Karen Canfell5 , Mark Einstein6 , Christopher Farley7 , Joseph Monsonego8 and Silvia Franceschi9

Int J Cancer. 2017 May 15;140(10):2192-2200

eurogin-2014-roadmap.jpg

EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection

Anna R. Giuliano1 , Alan G. Nyitray2 , Aimee R. Kreimer 3 , Christine M. Pierce Campbell1 , Marc T. Goodman4 , Staci L. Sudenga1 , Joseph Monsonego5 and Silvia Franceschi6

Int J Cancer. 2015 Jun 15;136(12):2752-60

eurogin-2011-roadmap.jpg

EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease

Marc Arbyn1*, Silvia de Sanjosé2 , Mona Saraiya3 , Mario Sideri4 , Joel Palefsky5 , Charles Lacey6 , Maura Gillison7 , Laia Bruni2 , Guglielmo Ronco8 , Nicolas Wentzensen9 , Julia Brotherton10, You-Lin Qiao11, Lynnette Denny12, Jacob Bornstein13, Laurent Abramowitz14, Anna Giuliano15, Massimo Tommasino16, Joseph Monsonego17

Int J Cancer. 2012 Nov 1;131(9):1969-82

eurogin-2011-roadmap.jpg

EUROGIN 2008 roadmap on cervical cancer prevention

Silvia Franceschi1 , Jack Cuzick2 , Rolando Herrero3 , Joakim Dillner4 and Cosette M. Wheeler5*

Int J Cancer. 2009 Nov 15;125(10):2246-55

eurogin-2007-roadmap-on-cervical-cancer.

EUROGIN 2007
Patient Education Conference Report
Part 1

EUROGIN 2006
Recommendations guidelines

eurogin-2007-roadmap-on-cervical-cancer.

EUROGIN 2003
Recommendations guidelines

8. Test HPV

detection-of-human-papillomavirus-genoty

Detection of Human Papillomavirus Genotypes Among High-Risk Women: A Comparison of Hybrid Capture and Linear Array Tests.

(Sex Transm Dis. 2008 May;35(5):521-7)

detection-of-human-papillomavirus-genoty

Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia.

(Int J Gynecol Cancer. 2006 Mar-Apr;16(2):591-8 )

detection-of-human-papillomavirus-genoty

Immunocytochemistry in Liquid-Based Cytology Samples in Equivocal Pap Smears.

(Acta Cytol. 2007 Sep-Oct;51(5):755-66) 

9. Recherche

papillomavirus-et-cancer.jpg

Papillomavirus et cancer du col de l’utérus.

estrogen-and-progesterone.jpg

Estrogen and progesterone receptors in Cervical HPV related lesions.

(Gynecol Oncol. 2005 Mar;96(3):830-9.)

10. Condylome acuminé

Condylome-acumine.jpg

Incidence, prise en charge et coût des condylomes acuminés anogénitaux chez les femmes consultant leur gynécologue en France.

(Gynecol Obstet Fertil. 2007 Feb;35(2):107-13)

11. Anus

Cancer-anal-et-papillomavirus-humains.jp

Cancer anal et papillomavirus humains : une pathologie en miroir de celle du cancer du col utérin.

(Gynécologie Obstétrique & Fertilité, 38 (2010) 250–254)

12. Cancers ORL/Multifocaux

cancers-or-multifocaux.jpg

Is there an increased risk of cancer among spouses of patients with an HPV-related cancer: A systematic review.

(Oral Oncology 67 (2017) 138–145)

Date de dernière mise à jour : jeudi 24 avril 2019